共 5 条
[1]
Differential effects of anti-beta 2-glycoprotein and antiprothrombin antibodies on the anticoagulant activity of activated protein C. Galli M,Ruggeri L,Barbui T. Blood . 1998
[2]
Role of factor ⅤLeiden mutation in patients with angiographically demonstrated coronary artery disease. Dunn ST,Roberts CR,Schecher E,et al. Thrombosis Research . 1998
[3]
Combination of activated protein C resistance and antibodies to phospholipids in the development of thrombosis. Bokarewa MI,Blomback M. Seminars in Hematology . 1997
[4]
Studies on phospholipid antibodies, APC resistance and associated mutation in the coagulation factorⅤgene. Bokarewa MI,Bremme K,Falk G,et al. Thrombosis Research . 1995
[5]
Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant respose to activated protein C: prediction of cofactor to activated protein C. Dahlback B,Carlsson M,Sevesson PJ,et al. Proceedings of the National Academy of Sciences of the United States of America . 1993